name: Ablative resurfacing of skin of lip using laser


name: Ablative resurfacing of skin of eyelid using laser


name: Open reduction of fracture of proximal fibula with internal fixation


name: Quantitative measurement of ratio of chromium to creatinine in 24 hour urine


name: Manual reduction of dislocation of metacarpophalangeal joint with percutaneous skeletal fixation


name: Open reduction of intertrochanteric fracture of femur with internal fixation using intramedullary implant, screw, and cerclage wiring


name: Excision of ruptured appendix by open approach


name: Positron emission tomography using fluorodeoxyglucose with computed tomography electrocardiography gated myocardial rest study


name: Child examination at 7 months with explicit context


name: Child examination at 8 weeks with explicit context


name: Factor VIII mutation carrier detection test


name: Incisional biopsy of interphalangeal joint of toe


name: Quantitative measurement of mass concentration of hydrocortisone in p.m. serum or plasma


name: Analysis of genome using melting curve technique


name: Quantitative measurement of glucose in peritoneal dialysis fluid specimen


name: Quantitative measurement of hydrocortisone in saliva specimen


name: Radionuclide imaging with computed tomography attenuation correction and diagnostic study


name: Open reduction of bicondylar fracture of tibia with internal fixation


name: Debridement of skin and subcutaneous tissue with removal of foreign body


name: Bilateral insertion of catheter with bilateral venous sampling


name: Repair and augmentation of bone of face using autogenous bone graft


name: Analysis using conformation sensitive capillary electrophoresis


name: Detection of mutation in apolipoprotein B-100 gene


name: Quantitative measurement of glucose in predialysis peritoneal dialysis fluid specimen


name: Fine needle aspiration biopsy of mass of parotid salivary gland


name: Excision of neoplasm of chest wall including rib


name: Sequential occupational dexterity assessment


name: Repair of total anomalous pulmonary venous connection to right atrium


name: Single photon emission computed tomography using iodine 123 meta-iodobenzylguanidine with computed tomography


name: Severity of alcohol dependence questionnaire score


name: Analysis using gene copy number technique


name: Analysis using denaturing gradient gel electrophoresis


name: Single photon emission computed tomography of ventilation and perfusion of lung


name: Ages and stages questionnaire second edition


name: Detection of ordinal level of hemoglobin F in amniotic fluid


name: Internal and external hemorrhoidectomy and anal fissurectomy


name: Number of mitotic figures per square millimeter


name: Recommendation of Rh>o<(D) immune globulin dose


name: Subcostal view of cardiac outlets directed anteriorly


name: SPECT CT of kidney using dimercaptosuccinic acid


name: Single photon emission using iodine 123 meta-iodobenzylguanidine computed tomography with computed tomography of heart


name: Subcostal short axis view at mitral valve level


name: Single photon emission computed tomography with computed tomography using radiolabeled octreotide


name: Assessment using Tinetti balance and gait scale


name: Measurement of amino acid in serum or plasma specimen using screening technique


name: Measurement of Epstein Barr virus antibody to viral capsid antigen, IgG and IgM in serum or plasma specimen


name: Assessment of consciousness level using Adelaide pediatric modified Glasgow coma scale


name: Quantitative measurement of IgM in urine specimen


name: Rate of leakage flow around cardiovascular device


name: Insertion of dual chamber cardiac pacemaker pulse generator


name: Caudal 10 degree distal-cranioproximal oblique projection


name: Reconstruction of breast with immediate insertion of breast prosthesis


name: Excision of neoplasm of soft tissue of scalp


name: Transplantation of muscle flap to upper extremity


name: Quantitative measurement of bicarbonate in arterial blood specimen


name: Ultrasonography guided aspiration of cyst of breast


name: Direct laryngoscopy with excision of neoplasm using operating microscope


name: Single and double simultaneous visual stimulation test


name: Bidirectional Glenn shunt procedure of left superior vena cava


name: Excision of cyst of mandible with partial excision of mandible by extraoral approach


name: Reconstruction of ramus of mandible by sagittal split osteotomy with internal fixation


name: Calculation of quantitative glomerular filtration rate based on creatinine concentration in serum or plasma


name: Analysis using chain termination sequencing technique


name: Single photon emission computed tomography with computed tomography of hemangioma of liver


name: Child examination at 2.5 years with explicit context


name: Quantitative measurement of mass concentration of albumin in serum or plasma specimen using bromcresol green technique


name: Quantitative measurement of 7-aminonitrazepam in saliva specimen


name: Quantitative measurement of creatinine in peritoneal fluid specimen


name: CT guided percutaneous drainage of abscess of peritoneum


name: CT guided percutaneous drainage of abscess of retroperitoneum


name: Quantitative measurement of mass concentration ratio of excretion of histamine to excretion of creatinine in 24 hour urine


name: Endoscopic excision of polyp of large intestine using sigmoidoscope


name: Application of multiplane external fixation system


name: Percutaneous radiofrequency ablation of neoplasm of bone


name: CT guided drainage of abscess of lymph node


name: Detection of chromosomal aneuploidy in prenatal amniotic fluid specimen using FISH screening technique


name: Measurement of antibody to Erlichia chaffeensis, IgG and IgM in serum or plasma specimen


name: Excision of infected vascular graft of abdomen


name: Open reduction of closed fracture of shaft of radius with external fixation


name: Measurement of pH of plasma of venous cord blood specimen at 37 degrees Celsius


name: Quantitative measurement of temazepam in saliva specimen


name: Quantitative measurement of IgA in 24 hour urine specimen


name: Excision of neoplasm of soft tissue of face


name: Quantitative measurement of benzoylecgonine in urine using GC-MS


name: Quantitative measurement of IgG in 24 hour urine specimen


name: Quantitative measurement of IgM in serum specimen


name: Quantitative measurement of phencyclidine in serum or plasma using GC-MS


name: Quantitative measurement of mass concentration of ciclosporin in serum or plasma using enzyme immunoassay


name: Detection of ordinal level of hemoglobin F in blood


name: Quantitative measurement of mass concentration of chromium in peripheral blood


name: Quantitative measurement of IgA in cerebrospinal fluid specimen


name: Quantitative measurement of glucose in serum or plasma specimen 6 hours after glucose challenge


name: Single photon emission computed tomography with computed tomography technetium-99m hexamethylpropyleneamine oxime leukocyte scan


name: Single photon emission computed tomography using iodine 123 with computed tomography of whole body


name: Lymph node station of involved lymph nodes


name: CT guided pneumonostomy with open drainage of abscess of lung


name: angioplasty of brachiocephalic artery using radiologic guidance


name: Bidirectional Glenn shunt procedure of right superior vena cava


name: Fine needle aspiration biopsy of superficial mass of thyroid


name: Removal of foreign body from subcutaneous tissue by incision


name: Child examination at 21 months with explicit context


name: Quantitative measurement of IgG in body fluid specimen


name: Measurement of Hepatitis B surface antigen and Hepatitis C antibody


name: Augmentation of chin using sliding osteotomy and interpositional autograft


name: Quantitative measurement of IgA in urine specimen


name: Large Allen cognitive level screening tool


name: Grafting of bone to spine using cancellous bone chip allograft


name: Reconstruction of toenail bed with nail bed graft


name: Measurement of Leptospira interrogans serovar Grippotyphosa antibody


name: Detection of mutation in low density lipoprotein receptor gene


name: Quantitative measurement of concentration of flurazepam and flurazepam metabolite in serum or plasma specimen


name: CT angiography of vascular structure of spine with contrast


name: Percutaneous embolization of coronary arteriovenous fistula using fluoroscopic guidance with contrast


name: Repair of total anomalous pulmonary venous connection of intracardiac type


name: Sequencing of entire coding region of gene


name: Quantitative measurement of substance rate of glucose excretion in urine


name: Testing for known gene mutation in family member


name: Measurement of arterial closing pressure


name: Recipient of biological material from subject


name: Quantitative measurement of calprotectin in stool specimen


name: Quantitative measurement of mass rate of excretion of creatinine in timed urine


name: Radiotherapy procedure with explicit context


name: Quantitative measurement of benzodiazepine in urine using GC-MS


name: Quantitative measurement of nitrazepam in saliva specimen


name: Dermabrasion of tattoo of external genitalia


name: Partial thickness debridement of skin of neck


name: Canadian occupational performance measure score


name: Insertion of transvenous electrode of dual chamber pacing cardioverter defibrillator pulse generator


name: Insertion of dual chamber pulse generator and repositioning of cardioverter defibrillation pulse generator lead


name: Quantitative measurement of IgM in body fluid specimen


name: Quantitative measurement of flurazepam in serum or plasma specimen


name: Quantitative measurement of mass concentration of prostate specific antigen in serum or plasma


name: Quantitative measurement of mephenytoin and normephenytoin in serum or plasma specimen


name: Quantitative measurement of mass concentration of hydrocortisone in serum or plasma obtained at a specified time


name: Measurement of disaccharidase activity of intestine


name: Repair of partial anomalous pulmonary venous connection by unroofing of coronary sinus with patch closure of interatrial communication


name: Modular arrangement of predetermined time standards scoring tool


name: Percutaneous sclerotherapy of venous malformation using fluoroscopic guidance with contrast


name: Quantitative measurement of IgA in body fluid specimen


name: Quantitative measurement of dextropropoxyphene in serum or plasma using GC-MS


name: Measurement of Hepatitis B surface antibody and Hepatitis C antibody


name: Quantitative measurement of mass concentration of creatinine in serum or plasma specimen using colorimetric enzyme technique


name: Measurement of spotted fever group rickettsia antibody


name: Excision of benign neoplasm of mandible with partial excision of mandible by extraoral approach


name: Percutaneous ablation of trigeminal nerve using fluoroscopic guidance


name: Percutaneous insertion of pulmonary valve using fluoroscopic guidance


name: Transapical implantation of aortic valve


name: Quantitative measurement of mass content of cocaine metabolite in meconium specimen using gas chromatography mass spectrometry


name: Analysis using PCR polyacrylamide gel electrophoresis


name: Quantitative measurement of mass concentration of bismuth in serum or plasma


name: Falls risk assessment score for the elderly (observable entity)


name: Quantitative measurement of concentration of codeine in oral fluid


name: Detection of factor V Leiden mutation and prothrombin G20210A mutation


name: Measurement of pH of plasma of arterial blood specimen at 37 degrees Celsius


name: Sensory integration inventory revised for individuals with developmental disabilities


name: Lifestyle education regarding hypertension


name: Exercise tolerance test using technetium (99m-Tc) tetrofosmin


name: Repair of partial anomalous pulmonary venous connection by baffle redirection to left atrium with reimplantation of systemic vein in right atrium


name: Exposure to anaerobic bacterial vaginosis


name: Quantitative measurement of histamine in urine specimen


name: Quantitative measurement of cortisol in baseline serum or plasma specimen after ACTH challenge


name: Diagnostic amniocentesis using ultrasound guidance


name: Doppler ultrasonography of arterial inflow and venous outflow of abdominal, pelvic and retroperitoneal organs


name: Composite autograft with primary closure of donor site


name: Quantitative measurement of cannabinoids in urine using GC-MS


name: Single photon emission computed tomography with computed tomography cardiac stress ventriculography


name: Single photon emission computed tomography with computed tomography scintimammography


name: Transluminal implantation of aortic valve


name: Repair of partial anomalous pulmonary venous connection by anastomosis of pulmonary venous confluence to left atrium via connecting vein


name: Percutaneous balloon compression of trigeminal nerve using fluoroscopic guidance


name: Exposure to Influenza A virus subtype H1N1


name: Tinetti balance and gait evaluation total score


name: Quantitative measurement of ethylene glycol in urine specimen


name: Measurement of alpha fetoprotein and analysis of chromosomes in amniotic fluid specimen


name: Quantitative measurement of ratio of free deoxypyridinoline relative to creatinine in urine specimen


name: Quantitative measurement of mass concentration of creatinine corrected for glucose concentration in overnight peritoneal dialysis fluid


name: Single photon emission computed tomography of myocardial perfusion using technetium 99m meta-iodobenzylguanidine tetrofosmin


name: Excision of subcutaneous neoplasm of foot


name: Reconstruction of ramus of mandible by horizontal osteotomy with grafting of bone


name: Percutaneous drainage of retroperitoneal abscess using ultrasound guidance


name: Percutaneous needle biopsy of pleura using ultrasound guidance


name: Assessment using Bristol stool form scale


name: Needle localization using ultrasound guidance and mammography


name: Curettage of benign neoplasm of phalanx of finger with autograft


name: Pharmacological challenge with Class l antiarrhythmic drug to unmask ST elevation


name: Percutaneous cholecystostomy and drainage using ultrasound guidance


name: Analysis using quantitative fluorescent PCR


name: Analysis of genome using heteroduplex technique


name: Percutaneous insertion of stent into coarctation of aorta using fluoroscopic guidance with contrast


name: Single photon emission computed tomography using thallium with computed tomography of brain


name: Assessment using vestibular disorders activities of daily living scale


name: Single photon emission computed tomography with computed tomography of bone


name: Open fixation of fracture of shaft of tibia using intramedullary implant


name: Open repair of distal tibiofibular joint


name: Nerve block with injection of cervical spine using fluoroscopic guidance


name: Quantitative measurement of fluoride in urine specimen


name: Le Fort I osteotomy of maxilla into one segment with grafting of bone


name: Detection of Arg3527Gln mutation in apolipoprotein B-100 gene


name: Quantitative measurement of glucose in first peritoneal dialysis fluid specimen


name: Application of intermittent pneumatic compression device


name: Single photon emission computed tomography with computed tomography indium 111 leukocyte study


name: Nerve block with injection of lumbar spine using fluoroscopic guidance


name: Calculation of quantitative volume rate of glomerular filtration based on cystatin C concentration in serum or plasma specimen


name: Calculation of quantitative volume rate of glomerular filtration based on concentration of analyte in serum or plasma specimen


name: Measurement of factor VIII activity by chromogenic method


name: Reamputation of lower leg through tibia and fibula


name: Open reduction of dislocation of knee with internal fixation and repair of ligament


name: Percutaneous radiofrequency ablation of lesion of liver using ultrasound guidance


name: Insertion of bone pin with skeletal traction


name: Insertion of balloon catheter into breast for radiotherapy


name: Percutaneous division of Achilles tendon


name: Percutaneous biopsy of liver using ultrasound guidance


name: Revision of gastrojejunal anastomosis with reconstruction with vagotomy


name: Identification of arsenic and/or arsenic compound


name: Excision of lesion of breast without wire guidance


name: Limited thoracotomy and biopsy of pleura


name: Child examination at 1 year with explicit context


name: Extraction of obstructive material from central venous device


name: Surgical removal of prosthetic implant from abdominal wall


name: Analysis using oligonucleotide ligation assay


name: Quantitative measurement of nordazepam in saliva specimen


name: Guided self-help cognitive behavioral therapy


name: Child examination at 8 to 9 months with explicit context


name: Incision and drainage of fluid collection of skin


name: Single photon emission computed tomography with computed tomography ventriculography at cardiac rest


name: Fluoroscopy guided percutaneous embolization of fistula of cerebral dura mater with contrast


name: Single photon emission computed tomography with computed tomography of liver and spleen


name: Transfer of tibialis posterior tendon through interosseous membrane of leg


name: Counseling procedure with explicit context


name: Measurement of fractionated estrogens in serum or plasma


name: Quantitative measurement of pyridinoline in 24 hour urine specimen


name: Provision of personal alarm device with link to provider service


name: Activities specific balance confidence scale


name: Exposure to Severe acute respiratory syndrome coronavirus


name: Esophagogastroduodenoscopy with directed submucosal injection


name: Incision of stomach and suture of bleeding gastric ulcer


name: Excision of part of colon and excision of terminal ileum with ileocolic anastomosis


name: Excision of part of colon with mobilization of splenic flexure


name: Revision of skin pocket for single chamber pacing cardioverter defibrillator


name: Fluoroscopy guided percutaneous embolization of pulmonary collateral artery with contrast


name: Single photon emission computed tomography with computed tomography of neoplasm


name: Open reduction of fracture of metacarpal with external fixation


name: Quantitative measurement of immunoglobulin G and immunoglobulin M and immunoglobulin A and immunoglobulin light chain in serum or plasma


name: Quantitative measurement of follicle stimulating hormone in baseline serum or plasma specimen


name: Quantitative measurement of beryllium in urine specimen


name: Child examination at birth with explicit context


name: Number of sentinel lymph nodes examined by microscopy in excised tissue specimen


name: Revision of skin pocket for dual chamber pacing cardioverter defibrillator


name: Single photon emission computed tomography with computed tomography of bone of head and neck


name: Confusion, Respiratory Rate, Blood Pressure, 65 years of age or older score (assessment scale)


name: Determination of alpha-1-antitrypsin genotype


name: Quantitative measurement of IgA in cord blood specimen


name: Quantitative measurement of cryoglobulin in serum specimen


name: Measurement of Murray Valley encephalitis virus antibody


name: Thoracoscopic excision of neoplasm of pericardium


name: Mobilization of splenic flexure of colon


name: Open reduction of fracture of carpal bone


name: Ordinal level of hemoglobin A1c (observable entity)


name: Subcostal short axis view at aortic valve level


name: Subcostal short axis view at venous inflow level


name: Measurement of Leptospira kirschneri serovar Grippotyphosa antibody


name: Sliding osteotomy of chin with single piece implant


name: Arthrocentesis and injection of intermediate joint


name: Parasternal long axis view of right ventricular inflow tract


name: Parasternal long axis view of right ventricular outflow tract


name: Insertion of transvenous electrode of single chamber pacing cardioverter defibrillator pulse generator


name: Replacement of dual chamber pulse generator


name: Broselow Luten color coding system for pediatric weight estimation


name: Reconstruction of ramus of mandible by vertical osteotomy with grafting of bone


name: Total excision of nail and nail matrix with amputation of tuft of distal phalanx


name: Fine needle aspiration biopsy using imaging guidance


name: MRI of brain with contrast using isotropic resolution


name: Percutaneous insertion of aortic valve using fluoroscopic guidance


name: Open revision of arteriovenous fistula using graft with removal of thrombus


name: Two dimensional transesophageal echocardiography with spectral display


name: Percutaneous needle biopsy of lung using ultrasound guidance


name: Percutaneous needle biopsy of the thyroid using ultrasound guidance


name: Child occupational self assessment version 2.1


name: Activities specific balance confidence score


name: Excision of foreign body of subcutaneous tissue


name: Transplantation of muscle flap to lower extremity


name: Repair of total anomalous pulmonary venous connection to right atrium by atrial septum translocation


name: Fluoroscopy of programmable cerebrospinal fluid shunt


name: Analysis using single strand conformation polymorphism technique


name: Quantitative measurement of creatinine in 2 hour postperitoneal dialysis fluid specimen


name: Repair of total anomalous pulmonary venous connection by unroofing and closure of coronary sinus and interatrial communication


name: Percutaneous insertion of stent into major aortopulmonary collateral artery using fluoroscopic guidance with contrast


name: Quantitative measurement of gastrin in fasting serum or plasma specimen


name: Factor II (prothrombin) G20210A mutation detection


name: Three dimensional rotational fluoroscopic angiography with contrast


name: Structural grafting of bone to spine using allograft


name: Computed tomography with contrast for measurement of brain volume


name: Transplantation of free osteocutaneous flap from iliac crest using microvascular anastomosis


name: Excision of rectum with anastomosis of colon to anus and creation of colonic reservoir


name: Repair of total anomalous pulmonary venous connection by creation of left neoatrium with pericardial roof


name: Insertion of temporary transvenous electrode of dual chamber cardiac pulse generator


name: Injection of sentinel lymph node using ultrasound guidance


name: Augmentation of mandible using bone graft


name: Incision and drainage of submucosal perirectal abscess by transanal approach


name: SNOMED Clinical Terms version: 20100131 [R] (January 2010 Release)


name: EGFR gene exon 20 insertion:Arb:Pt:Bld/Tiss:Ord:Molgen


name: Direct antiglobulin test.complement C3d specific reagent:PrThr:Pt:RBC:Ord


name: Direct antiglobulin test.complement C3d specific reagent


name: Direct antiglobulin test.IgA specific reagent:PrThr:Pt:RBC:Ord


name: Direct antiglobulin test.IgA specific reagent


name: Direct antiglobulin test.IgG specific reagent:PrThr:Pt:RBC:Ord


name: Direct antiglobulin test.IgM specific reagent:PrThr:Pt:RBC:Ord


name: Direct antiglobulin test.IgM specific reagent


name: Leukocytes^^corrected for nucleated erythrocytes:NCnc:Pt:Bone mar:Qn


name: Lupus anticoagulant neutralization.high phospholipid.factor substitution^immediately after 1:2 addition of saline:Time:Pt:PPP:Qn:Coag


name: Lupus anticoagulant neutralization.high phospholipid.factor substitution^immediately after 1:2 addition of platelet lysate:Time:Pt:PPP:Qn:Coag


name: Platelet aggregation.adenosine diphosphate induced^2.5 umol/L:PrThr:Pt:PRP:Ord


name: Platelet aggregation.adenosine diphosphate induced^5 umol/L:PrThr:Pt:PRP:Ord


name: Platelet aggregation.ristocetin induced^1125 mg/L:PrThr:Pt:PRP:Ord


name: Platelet aggregation.ristocetin induced^1000 mg/L:PrThr:Pt:PRP:Ord


name: Platelet aggregation.ristocetin induced^500 mg/L:PrThr:Pt:PRP:Ord


name: Platelet aggregation.collagen induced^5 ug/mL:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.ristocetin induced^250 ug/mL:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.adenosine diphosphate induced ATP secretion^10 umol/L:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.adenosine diphosphate induced ATP secretion


name: Platelet aggregation.arachidonate induced ATP secretion^500 umol/L:PrThr:Pt:Bld:Ord


name: Platelet aggregation.arachidonate induced ATP secretion


name: Platelet aggregation.arachidonate induced ATP secretion^500 umol/L:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.collagen induced ATP secretion^5 ug/mL:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.collagen induced ATP secretion


name: Pancreatic islet cell Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Insulin^16H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^20H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^1D post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: SCL-70 extractable nuclear Ab:PrThr:Pt:Ser:Ord:IB


name: Legionella pneumophila Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IF


name: Macular grid.outer superior subfield thickness:Len:Pt:Eye:Qn:OCT


name: Macular grid.outer nasal subfield thickness:Len:Pt:Eye:Qn:OCT


name: Macular grid.outer inferior subfield thickness:Len:Pt:Eye:Qn:OCT


name: Macular grid.outer temporal subfield thickness:Len:Pt:Eye:Qn:OCT


name: Optical coherence tomography panel:-:Pt:Eye:Qn:OCT


name: Type of nursing provider:Type:Pt:{Nursing unit}:Nom:NMMDS


name: Cholesterol ester transfer protein:ACnc:Pt:Ser/Plas:Qn


name: Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase:CRto:Pt:Amnio fld cells:Qn


name: Interleukin 1 receptor alpha chain:MCnc:Pt:Ser/Plas:Qn


name: Interleukin 1 receptor alpha chain.soluble:MCnc:Pt:Ser/Plas:Qn


name: SBM sphere far:InvLen:Pt:Corrective lens.right:Qn:Lensmeter


name: SBM visual acuity far:LenRto:Pt:Corrective lens.left:Qn:Lensmeter


name: Prism base direction:Angle:Pt:Corrective lens.right:Qn:Lensmeter


name: Sphere near 1:InvLen:Pt:Glasses prescription.lens.left:Qn


name: Pupillary distance.monocular near:Len:Pt:Glasses prescription.lens.left:Qn


name: Over refraction sphere:InvLen:Pt:Contact lens.right:Qn


name: Over refraction cylinder:InvLen:Pt:Contact lens.right:Qn


name: Over refraction axis:Angle:Pt:Contact lens.right:Qn


name: Platelet aggregation.adenosine diphosphate induced ATP secretion^5 umol/L:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.adenosine diphosphate induced ATP secretion^10 umol/L:PrThr:Pt:Bld:Ord


name: Platelet aggregation.adenosine diphosphate induced ATP secretion^5 umol/L:PrThr:Pt:Bld:Ord


name: Platelet aggregation.adenosine diphosphate induced^5 umol/L:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.adenosine diphosphate induced^10 umol/L:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.arachidonate induced^500 umol/L:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.collagen induced^1 ug/mL:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.collagen induced ATP secretion^1 ug/mL:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.collagen induced ATP secretion^1 ug/mL:PrThr:Pt:Bld:Ord


name: Platelet aggregation.collagen induced ATP secretion^5 ug/mL:PrThr:Pt:Bld:Ord


name: Platelet aggregation.thrombin induced ATP secretion^5 U/mL:PrThr:Pt:Bld:Ord


name: Platelet aggregation.thrombin induced ATP secretion


name: Platelet aggregation.thrombin induced ATP secretion^1 U/mL:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.thrombin induced ATP secretion^5 U/mL:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.thrombin induced ATP secretion^1 U/mL:PrThr:Pt:Bld:Ord


name: ACE gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Foot and mouth disease virus RNA:ACnc:Pt:XXX:Qn:Probe.amp.tar


name: Influenza virus A N1 RNA:ACnc:Pt:XXX:Qn:Probe.amp.tar


name: Ethambutol 8.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Pyrazinamide 300.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Platelet aggregation.ristocetin induced^1.0 mg/mL:RelACnc:Pt:Bld:Qn


name: Horizontal adduction.passive range of motion:Angle:Pt:Shoulder.right:Qn


name: Horizontal adduction.passive range of motion


name: Horizontal adduction.active range of motion:Angle:Pt:Shoulder.right:Qn


name: Horizontal adduction.passive range of motion:Angle:Pt:Shoulder.left:Qn


name: Horizontal adduction.passive range of motion:Angle:Pt:Shoulder:Qn


name: Horizontal adduction.active range of motion:Angle:Pt:Shoulder:Qn


name: Deprecated PhenX measure - neck circumference


name: Deprecated PhenX measure - pregnancy weight gain


name: Body weight^pre current pregnancy:Mass:Pt:^Patient:Qn


name: Weight gain^during current pregnancy:Mass:Pt:^Patient:Qn


name: Body weight^pre most recent pregnancy:Mass:Pt:^Patient:Qn


name: Weight gain^during most recent pregnancy:Mass:Pt:^Patient:Qn


name: Gestational age in W^at most recent delivery:Time:Pt:^Fetus:Qn


name: Deprecated PhenX measure - weight loss or gain


name: Body weight^XXX time ago:Mass:Pt:^Patient:Qn


name: Deprecated PhenX measure - waist circumference


name: Adult Waist Circumference Protocol:-:Pt:^Patient:-


name: Child Waist Circumference Protocol:-:Pt:^Patient:-


name: Phenx - hand dominance - 42Mo and older protocol 020601:-:Pt:^Patient:-:ALSPAC


name: Phenx - hand dominance - 42Mo and older protocol 020601


name: Hand dominance - drawing:Find:Pt:^Patient:Nom:ALSPAC


name: Hand dominance - throwing a ball:Find:Pt:^Patient:Nom:ALSPAC


name: Hand dominance - coloring:Find:Pt:^Patient:Nom:ALSPAC


name: Hand dominance - holding a toothbrush:Find:Pt:^Patient:Nom:ALSPAC


name: PhenX - hand dominance - 12Y and older protocol 020602:-:Pt:^Patient:-:EHI


name: PhenX - hand dominance - 12Y and older protocol 020602


name: Hand dominance - write:Find:Pt:^Patient:Nom:EHI


name: Hand dominance - draw:Find:Pt:^Patient:Nom:EHI


name: Hand dominance - throw:Find:Pt:^Patient:Nom:EHI


name: Hand dominance - hold a racquet:Find:Pt:^Patient:Nom:EHI


name: Hand dominance - clean teeth:Find:Pt:^Patient:Nom:EHI


name: Hand dominance - hammer:Find:Pt:^Patient:Nom:EHI


name: Hand dominance - strike a match:Find:Pt:^Patient:Nom:EHI


name: Hand dominance - use an eraser:Find:Pt:^Patient:Nom:EHI


name: Hand dominance - deal cards:Find:Pt:^Patient:Nom:EHI


name: Hand dominance - thread a needle:Find:Pt:^Patient:Nom:EHI


name: Hand dominance - cut food with a knife:Find:Pt:^Patient:Nom:EHI


name: Hand dominance - Total score:Score:Pt:^Patient:Qn:EHI


name: Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA:PrThr:Pt:Anal:Ord:Probe.amp.sig


name: CHIC2 gene 4q12 deletion:Find:Pt:Bld/Tiss:Doc:FISH


name: Smith extractable nuclear Ab & Ribonucleoprotein extractable nuclear Ab panel:-:Pt:Ser:Qn


name: Smith extractable nuclear Ab & Ribonucleoprotein extractable nuclear Ab panel


name: Beta 2 glycoprotein & Cardiolipin Ab & Phosphatidylserine panel:-:Pt:Ser:-


name: Beta 2 glycoprotein & Cardiolipin Ab & Phosphatidylserine panel


name: Beta 2 glycoprotein 1 Ab.IgA & IgG & IgM panel:-:Pt:Ser:Qn


name: Beta 2 glycoprotein 1 Ab.IgA & IgG & IgM panel


name: Date referral lab test results received:TmStp:XXX:Referral lab test:Qn


name: Candida albicans Ab.IgA & IgG & IgM panel


name: PCSK9 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: LDLR gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Glucose^4H post peritoneal dialysis:MCnc:Pt:Dial fld prt:Qn


name: Calculus analysis with calculus photography:Imp:Pt:Calculus:Nom


name: Calculus analysis with calculus photography


name: Hand dominance - 42Mo:Imp:Pt:^Patient:Nom:ALSPAC


name: Hand dominance - 12Y:Imp:Pt:^Patient:Nom:EHI


name: CYP2C9 gene allele 2:Prid:Pt:Bld:Nom:Molgen


name: CYP2C9 gene allele 3:Prid:Pt:Bld:Nom:Molgen


name: Brassica oleracea var italica Ab.IgG4:MCnc:Pt:Ser:Qn


name: Brassica oleracea var gemmifera Ab.IgG4:MCnc:Pt:Ser:Qn


name: Brassica oleracea var capitata Ab.IgG4:MCnc:Pt:Ser:Qn


name: Brassica oleracea var botrytis Ab.IgG4:MCnc:Pt:Ser:Qn


name: Cheese cheddar type Ab.IgG4:MCnc:Pt:Ser:Qn


name: Chrysops flavidus (whole body) Ab.IgG4:MCnc:Pt:Ser:Qn


name: Guinea pig epithelium Ab.IgG4:MCnc:Pt:Ser:Qn


name: Corylus avellana pollen Ab.IgG4:MCnc:Pt:Ser:Qn


name: Deprecated Melon IgG4 Ab [Mass/volume] in Serum


name: (Blatella germanica+Dermatophagoides farinae+Dermatophagoides pteronyssinus+House dust Hollister Stier) Ab.IgG4:MCnc:Pt:Ser:Qn


name: Prunus persica var nucipersica Ab.IgG4:MCnc:Pt:Ser:Qn


name: (Anacardium occidentale+Carya illinoinensis+Castanea sativa+Juglans spp+Pistacia vera) Ab.IgG4:MCnc:Pt:Ser:Qn


name: Avena sativa cultivated Ab.IgG4:MCnc:Pt:Ser:Qn


name: Olea europaea pollen Ab.IgG4:MCnc:Pt:Ser:Qn


name: Carya illinoinensis nut Ab.IgG4:MCnc:Pt:Ser:Qn


name: Carya illinoinensis tree Ab.IgG4:MCnc:Pt:Ser:Qn


name: Secale cereale pollen Ab.IgG4:MCnc:Pt:Ser:Qn


name: Cardiac heart disease risk:Ratio:Pt:Ser/Plas:Qn


name: Direct antiglobulin test.complement C3c specific reagent:PrThr:Pt:RBC:Ord


name: Direct antiglobulin test.complement C3c specific reagent


name: Salmonella sp antigenic formula:ID:Pt:Isolate:Nom:Aggl


name: Taenia solium larva Ab:PrThr:Pt:CSF:Ord:IA


name: Insulin^6M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^10M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^2H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^3H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Prolactin^2H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Androstenedione^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^45M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^6H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^7H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Somatotropin^8H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Corticotropin^15M post XXX challenge:MCnc:Pt:Plas:Qn


name: Corticotropin^45M post XXX challenge:MCnc:Pt:Plas:Qn


name: Corticotropin^2H post XXX challenge:MCnc:Pt:Plas:Qn


name: Dehydroepiandrosterone sulfate^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone sulfate^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^2M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Hepatitis E virus Ab.IgG:ACnc:Pt:Ser/Plas:Qn:IA


name: C peptide^6M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^45M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor-I^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor-I^45M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Vasopressin^1H post XXX challenge:MCnc:Pt:Plas:Qn


name: Androstenedione^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Beta 2 glycoprotein 1 Ab:ACnc:Pt:Ser:Qn:IA


name: Glutamate decarboxylase 65 Ab:ACnc:Pt:Ser:Qn:IA


name: Tubular basement membrane Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: U1 small nuclear ribonucleoprotein Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Sjogrens syndrome-A extractable nuclear 52kD Ab:ACnc:Pt:Ser:Qn:IA


name: Purkinje cell cytoplasmic type Tr Ab:Titr:Pt:Ser:SemiQn:IF


name: Purkinje cell cytoplasmic type Tr Ab:Titr:Pt:CSF:SemiQn:IF


name: Albumin:MRat:8H:Urine:Qn:Detection limit <= 20 mg/L


name: 11-Deoxycorticosterone^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Renin^10M post XXX challenge:CCnc:Pt:Plas:Qn


name: Aldosterone^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^4.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^5.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^6.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^7.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^8H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^9H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^9.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^10H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^10.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^11H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^11.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^20H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Renin^30M post XXX challenge:CCnc:Pt:Plas:Qn


name: Renin^1H post XXX challenge:CCnc:Pt:Plas:Qn


name: 17-Hydroxyprogesterone^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Risk factors affecting health status and or outcome:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Influenza virus vaccination received:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Reason pneumococcal vaccine not given:Find:Pt:^Patient:Nom:OASIS-C


name: Patient lives alone:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Patient lives with other person:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Patient lives in congregated situtation:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Ability to hear:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Understanding of verbal content:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Speech and oral expression of language:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Hydrogen/Expired gas^3H post dose lactulose:VFr:Pt:Exhl gas:Qn


name: Urinalysis dipstick W Reflex Culture panel:-:Pt:Urine:-


name: Urinalysis dipstick W Reflex Culture panel


name: Urinalysis dipstick W Reflex Microscopic panel:-:Pt:Urine:-


name: Urinalysis dipstick W Reflex Microscopic panel


name: Complete blood count W Auto Differential panel:-:Pt:Bld:Qn


name: Complete blood count W Auto Differential panel


name: Complete blood count W Reflex Manual Differential panel:-:Pt:Bld:Qn


name: Complete blood count W Reflex Manual Differential panel


name: Health Quality Measure document:Find:Pt:^Patient:Doc


name: Fetal chromosome 13+18+21+X+Y aneuploidy:Find:Pt:Tiss^Fetus:Nom:Molgen


name: Herpesviruses 6 DNA panel:-:Pt:XXX:-:Probe.amp.tar


name: Alternaria alternata Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Penicillium sp Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Cow milk Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Phadiatop inhalant allergen Ab.IgE:ACnc:Pt:Ser:Qn


name: Chromosome 13+18+21+X+Y aneuploidy:Find:Pt:Amnio fld:Nom:Molgen


name: Referral note:Find:Pt:{Setting}:Doc:Physical medicine and rehab


name: 17-Hydroxyprogesterone^45M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Renin^1.5H post XXX challenge:CCnc:Pt:Plas:Qn


name: Aldosterone^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Renin^20M post XXX challenge:CCnc:Pt:Plas:Qn


name: Insulin^12M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: C peptide^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^45M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^12M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^45M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone sulfate^45M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone sulfate^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Follitropin^10M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Follitropin^3H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: 11-Deoxycorticosterone^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycorticosterone^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycorticosterone^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycorticosterone^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycorticosterone^40M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycorticosterone^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycorticosterone^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycorticosterone^2.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor-I^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor-I^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Rheumatoid arthritis nuclear Ab:Titr:Pt:Ser:Ord:IF


name: Chicken droppings Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Dog dander+Dog epithelium Ab.IgE:ACnc:Pt:Ser:Qn


name: Nuclear pore protein gp210 Ab:PrThr:Pt:Ser:Ord:IB


name: PM-SCL extractable nuclear Ab:PrThr:Pt:Ser:Ord:IB


name: Ribonucleoprotein extractable nuclear Ab:PrThr:Pt:Ser:Ord:IB


name: Sjogrens syndrome-A extractable nuclear Ab:PrThr:Pt:Ser:Ord:IB


name: Sjogrens syndrome-B extractable nuclear Ab:PrThr:Pt:Ser:Ord:IB


name: Lolium perenne recombinant profilin Ab.IgE:ACnc:Pt:Ser:Qn


name: Olea europaea recombinant (rOle e) 2 Ab.IgE:ACnc:Pt:Ser:Qn


name: Smith extractable nuclear Ab:PrThr:Pt:Ser:Ord:IB


name: Jo-1 extractable nuclear Ab:PrThr:Pt:Ser:Ord:IB


name: Indirect antiglobulin test.XXX reagent:Titr:Pt:Ser/Plas:SemiQn


name: HIV 1+2 Ab+HIV1 p24 Ag:PrThr:Pt:Ser/Plas:Ord:IA


name: Formal pain assessment using standardized tool:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Formal pain assessment using standardized tool


name: Eosinophils/100 leukocytes:NFr:Pt:Synv fld:Qn:Manual count


name: Deprecated Protein.monoclonal.beta [Mass/volume] in Urine by Electrophoresis


name: Insulin-like growth factor binding protein 3^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor binding protein 3^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^2D post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Coxiella burnetii Ab.IgM^1st specimen:PrThr:Pt:Ser:Ord:IF


name: HEDIS 2010 Codes to identify physiologic monitoring tests - Serum potassium (MPM-A):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify physiologic monitoring tests - Serum potassium (MPM-A)


name: Reason for co-payment exemption:Find:Pt:^Patient:Doc


name: PCNA extractable nuclear Ab:PrThr:Pt:Ser:Ord:IB


name: Centromere protein B Ab:PrThr:Pt:Ser:Ord:IB


name: Estradiol^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Estradiol^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^2.17H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: APOB gene+LDLR gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Aldosterone^100M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^70M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Renin^100M post XXX challenge:CCnc:Pt:Plas:Qn


name: Renin^70M post XXX challenge:CCnc:Pt:Plas:Qn


name: Liver kidney microsomal Ab:PrThr:Pt:Ser:Ord:IB


name: Protein fractions.oligoclonal bands.IgG:PrThr:Pt:CSF:Ord:Isoelectric focusing


name: Protein fractions.oligoclonal bands.IgM:PrThr:Pt:CSF:Ord:Isoelectric focusing


name: CYP21A2 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: (Canary feather+Parakeet feather+Parrot feather) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk


name: Insulin^28H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Insulin^32H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Insulin^36H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Emergency contact information panel:-:Pt:^Emergency contact:-


name: Date and time ED consult request initiated:TmStp:Pt:^Patient:Qn


name: Date and time ED consult starts:TmStp:Pt:^Patient:Qn


name: ED accepting or admitting provider:ID:Pt:Provider:Nom


name: ED accepting or admitting facility:ID:Pt:Facility:Nom


name: Primary care clinic or system:ID:Pt:Facility:Nom


name: Provider who accepted patient in transfer to another facility:ID:Pt:Provider:Nom


name: Individuals accompanying patient to ED:Prid:Pt:^Patient:Nom


name: Time placed into treatment area:TmStp:Pt:^Patient:Qn


name: Problem response to therapy:Find:Pt:^Patient:Nom


name: Problem quality or description:Find:Pt:^Patient:Nom


name: Symptom duration during occurrences or episodes:Time:Pt:^Patient:Qn


name: Limitations in obtaining history:Find:Pt:^Patient:Nom


name: Problem associated signs and symptoms:Find:Pt:^Patient:Nom


name: Viability of current pregnancy:Find:Pt:^Patient:Nar


name: Pain severity verbal numeric scale:Score:Pt:^Patient:Qn


name: Pain severity descriptive category:Arb:Pt:^Patient:Ord


name: Pulse strength on exam:Find:Pt:^Patient:Nar


name: Calculated & derived values:Cmplx:-:^Patient:Set


name: Interpretation and review of laboratory results:Imp:Pt:^Patient:Nom


name: Interpretation and review of laboratory results


name: Care process or plan:Prid:Pt:^Patient:Nom


name: Amount of ED discharge medication to be dispensed:Num:Pt:^Patient:Qn


name: Amount of ED discharge medication to be dispensed


name: Provider assuming ultimate responsibility for care for patient upon ED disposition:ID:Pt:Provider:Nom


name: Provider assuming care for patient upon ED disposition:ID:Pt:Provider:Nom


name: Time accepted for admission or transfer:TmStp:Pt:^Patient:Qn


name: Time received by accepting facility or unit:TmStp:Pt:^Patient:Qn


name: Date and time of ED departure:TmStp:Pt:^Patient:Qn


name: ED follow-up care assistance:Type:Pt:^Patient:Nom


name: Relationship to patient:Type:Pt:^Emergency contact:Nom


name: Onset of painful contractions:TmStp:Pt:^Patient:Qn


name: Continuous ST segment monitoring:Complex:-:^Patient:Set


name: Symptoms & diseases:Hx:Pt:Gynecologic system:Nar


name: Physical findings:Find:Pt:Brain stem reflexes:Nar


name: Serology & blood bank studies:Complex:-:^Patient:Set


name: Mixed venous oxygen saturation monitoring:Cmplx:-:^Patient:Set


name: Mixed venous oxygen saturation monitoring


name: TCRB gene+TCRD gene+TCRG gene rearrangements:Arb:Pt:Bld/Tiss:Ord:Molgen


name: Parietaria judaica recombinant (rPar j) 2 Ab.IgE:ACnc:Pt:Ser:Qn


name: BCHE gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Cells.terminal deoxyribonucleotidyl transferase/100 cells:NFr:Pt:CSF:Qn:Flow cytometry


name: Chlamydia sp Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn:IA


name: Chlamydia sp Ab.IgG^2nd specimen:ACnc:Pt:Ser:Qn:IA


name: Coxiella burnetii Ab.IgM^2nd specimen:ACnc:Pt:Ser:Qn:IF


name: Coxiella burnetii Ab.IgM^1st specimen:Titr:Pt:Ser:SemiQn:IF


name: Coxiella burnetii Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IF


name: Coxiella burnetii Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IF


name: Fractional excretion of phosphate:Ratio:24H:Urine+Ser/Plas:Qn


name: Hepatitis C virus c1 Ab:PrThr:Pt:Ser:Ord:IB


name: Hepatitis C virus c2 Ab:PrThr:Pt:Ser:Ord:IB


name: Hepatitis C virus E2 Ab:PrThr:Pt:Ser:Ord:IB


name: Hepatitis C virus NS3 Ab:PrThr:Pt:Ser:Ord:IB


name: Hepatitis C virus NS4 Ab:PrThr:Pt:Ser:Ord:IB


name: Hydrogen/Expired gas^pre dose lactulose:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^1H post dose lactulose:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^2H post dose lactulose:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^2.5H post dose lactulose:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^3.5H post dose lactulose:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^1.5H post dose lactulose:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^30M post dose glucose:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^30M post dose lactulose:VFr:Pt:Exhl gas:Qn


name: Insulin^8H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Insulin^64H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Insulin^68H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Insulin^3D post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Insulin^56H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Insulin^2D post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Insulin^60H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Insulin^44H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Insulin^40H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Mycoplasma pneumoniae Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn:IA


name: Neuronal nuclear type 2 Ab:PrThr:Pt:CSF:Ord:IF


name: Neutrophils.segmented/100 leukocytes:NFr:Pt:Bone mar:Qn:Manual count


name: Protein fractions.oligoclonal bands:Imp:Pt:Ser/Plas:Nom:Isoelectric focusing


name: Renin^upright+30M post XXX challenge:MCnc:Pt:Plas:Qn


name: Renin^upright+1H post XXX challenge:MCnc:Pt:Plas:Qn


name: Rheumatoid arthritis nuclear Ab:Titr:Pt:Ser:SemiQn:IF


name: Taenia solium larva Ab:PrThr:Pt:Ser:Ord:IA


name: 11-Deoxycortisol^4D post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^4H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Hepatitis C virus Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Insulin^52H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Legionella pneumophila Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IF


name: Mycoplasma pneumoniae Ab.IgG^2nd specimen:ACnc:Pt:Ser:Qn:IA


name: Chromosome 12 aneuploidy:Find:Pt:Amnio fld/CVS:Nom:FISH


name: Deprecated Outcome and assessment information set (OASIS) form - version C


name: Outcome and assessment information set (OASIS) form - version C


name: Clinical record items:-:Pt:^Patient:-:CMS Assessment


name: Patient history and diagnoses:-:Pt:^Patient:-


name: Neuro & emotional & behavioral status - start of care or resumption of care:-:-:^Patient:-


name: Therapy need and plan of care:-:Pt:^Patient:-:CMS Assessment


name: Data items collected at inpatient facility admission or agency discharge only:-:Pt:^Patient:-


name: Labor and delivery admission history and physical note:Find:Pt:{Setting}:Doc:{Role}


name: Labor and delivery admission history and physical note


name: Labor and delivery summary note:Find:Pt:{Setting}:Doc:{Role}


name: Deprecated Maternal discharge summary note


name: Pregnancy visit summary note:Find:Pt:^Patient:Nar


name: Delivery date:Date:Pt:^Patient:Qn:Estimated from quickening date


name: Delivery date:Date:Pt:^Patient:Qn:Estimated from date fundal height reaches umb


name: Date fundal height reaches umbilicus:Date:Pt:^Patient:Qn


name: Body weight:Mass:Pt:^Fetus:Qn:Estimated by palpation


name: Date next clinic visit:Date:Pt:^Patient:Qn


name: Labor and delivery process:Find:Pt:^Patient:Nar


name: Newborn status at maternal discharge:Find:Pt:^Newborn:Nar


name: Antenatal testing and surveillance:Find:Pt:^Patient:Nar


name: Anesthesia risk review of systems:Find:Pt:^Patient:Nar


name: Fatty acid oxidation newborn screen panel:-:Pt:Bld.dot:-


name: Fatty acid oxidation newborn screen panel


name: Organic acid newborn screen panel:-:Pt:Bld.dot:-


name: Congenital adrenal hyperplasia newborn screening panel:-:Pt:Bld.dot:-


name: Congenital adrenal hyperplasia newborn screening panel


name: Biotinidase newborn screening panel:-:Pt:Bld.dot:-


name: Eosinophil cationic protein:MCnc:Pt:Nasal fluid:Qn


name: Cyclic citrullinated peptide Ab.IgA+IgG:ACnc:Pt:Ser/Plas:Qn:IA


name: Phenol^^adjusted to specific gravity 1.024:MCnc:Pt:Urine:Qn


name: Follitropin^10M pre dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Follitropin^1.5H post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Follitropin^1H post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Follitropin^30M post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Follitropin^20M post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^2H post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^1.5H post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^1H post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^30M post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^20M post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^10M pre dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Macular grid.center point thickness:Len:Pt:Eye:Qn:OCT


name: Macular grid.center subfield thickness:Len:Pt:Eye:Qn:OCT


name: Macular grid.inner superior subfield thickness:Len:Pt:Eye:Qn:OCT


name: Macular grid.inner nasal subfield thickness:Len:Pt:Eye:Qn:OCT


name: Macular grid.inner inferior subfield thickness:Len:Pt:Eye:Qn:OCT


name: Macular grid.inner temporal subfield thickness:Len:Pt:Eye:Qn:OCT


name: Type of client:Type:Pt:{Nursing unit}:Nom:NMMDS


name: Type of encounter:Type:Pt:{Nursing unit}:Nom:NMMDS


name: Volume of nursing delivery unit or service panel:-:Pt:{Nursing unit}:-:NMMDS


name: Volume of nursing delivery unit or service panel


name: Method of care delivery:Type:Pt:{Nursing unit}:Nom:NMMDS


name: Newborn Screening Report summary panel:-:Pt:^Patient:-


name: Unhealed pressure injury at Stage 2 or higher or designated as unstageable:Find:Pt:^Patient:Nom:OASIS-C


name: CYP11B1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: PRNP gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: SRY gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CYP11B1 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: PRNP gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: SRY gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Chromosome 13+18+21+X+Y aneuploidy:Find:Pt:Amnio fld/CVS:Nom:FISH


name: Risk for hospitalization:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: 11-Ketoetiocholanolone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Ketoetiocholanolone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Ketoetiocholanolone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Deoxycorticosterone^pre 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Toxoplasma gondii Ab.IgG & IgM panel:-:Pt:Ser:Qn


name: Metanephrine.free & Normetanephrine.free panel:SCnc:Pt:Ser/Plas:Qn


name: Metanephrine.free & Normetanephrine.free panel


name: Colorado tick fever virus Ab.IgG & IgM:Imp:Pt:Ser:Nar


name: Colorado tick fever virus Ab.IgG & IgM panel:Titr:Pt:Ser:SemiQn


name: Valproate.free & Valproate panel:-:Pt:Ser/Plas:Qn


name: Gliadin peptide Ab.IgA & IgG panel:-:Pt:Ser:-


name: Glucose-6-Phosphate dehydrogenase newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Glucose-6-Phosphate dehydrogenase newborn screening comment-discussion


name: Glucose-6-Phosphate dehydrogenase newborn screen panel:-:Pt:Bld.dot:-


name: Glucose-6-Phosphate dehydrogenase newborn screen panel


name: Acylcarnitine newborn screen panel:-:Pt:Bld.dot:-


name: Acylcarnitine newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Acylcarnitine newborn screening comment-discussion


name: Number of pressure ulcers present upon admission &or reentry - unstageable due to non-removable dressing:Num:Pt:^Patient:Qn:OASIS-C


name: Number of pressure ulcers present upon admission &or reentry - unstageable due to coverage of wound bed by slough &or eschar:Num:Pt:^Patient:Qn:OASIS-C


name: Number of pressure ulcers present upon admission &or reentry - unstageable with suspected deep tissue injury in evolution:Num:Pt:^Patient:Qn:OASIS-C


name: Full newborn screening summary report for display or printing:-:Pt:^Patient:Doc


name: Full newborn screening summary report for display or printing


name: Newborn screening report - overall interpretation:Imp:Pt:^Patient:Nom


name: Newborn conditions with positive markers:Prid:Pt:Bld.dot:Nom


name: Referral note:Find:Pt:{Setting}:Doc:Thoracic and cardiac surgery


name: Referral note:Find:Pt:{Setting}:Doc:Nutrition and dietetics


name: Referral note:Find:Pt:{Setting}:Doc:Oral and maxillofacial surgery


name: Pyruvate^5M post XXX challenge:MCnc:Pt:Bld:Qn


name: 18-Hydroxycorticosterone^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 18-Hydroxycorticosterone^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Hearing loss newborn screening comment-discussion:Txt:Pt:Ear:Nar


name: Hearing loss newborn screening comment-discussion


name: Infectious diseases newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Infectious diseases newborn screening comment-discussion


name: Hemoglobin disorders newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Hemoglobin disorders newborn screening comment-discussion


name: Galactosemias newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Galactosemias newborn screening comment-discussion


name: Congenital hypothyroidism newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Congenital adrenal hyperplasia newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Congenital adrenal hyperplasia newborn screening comment-discussion


name: Cystic fibrosis newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Cystic fibrosis newborn screening comment-discussion


name: Organic acidemias defects newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Organic acidemias defects newborn screening comment-discussion


name: Fatty acid oxidation defects newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Fatty acid oxidation defects newborn screening comment-discussion


name: Amino acidemias newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Amino acidemias newborn screening comment-discussion


name: Unique bar code number:ID:Pt:Initial sample:Nom


name: Highest level of education:Hx:Pt:^Mother:Ord


name: Referral note:Find:Pt:{Setting}:Doc:Critical Care Medicine


name: Referral note:Find:Pt:{Setting}:Doc:Obstetrics and Gynecology


name: Lupus anticoagulant neutralization.dilute phospholipid/Lupus anticoagulant neutralization.high phospholipid:Ratio:Pt:PPP:Qn:Coag


name: Lupus anticoagulant neutralization.dilute phospholipid/Lupus anticoagulant neutralization.high phospholipid


name: Inpatient procedure relevant to plan of care:-:Pt:^Patient:-


name: Inpatient procedure relevant to plan of care


name: Current number of unhealed pressure ulcers:-:Pt:^Patient:-


name: Number of pressure injuries at each stage:-:Pt:^Patient:Set


name: Number of pressure injuries present at admission:-:Pt:^Patient:Set


name: Stage 3 or 4 pressure injury with largest surface dimensions:-:Pt:^Patient:-


name: Deprecated Outcome and assessment information set (OASIS) form - version C - Start of care


name: Outcome and assessment information set (OASIS) form - version C - Start of care


name: Deprecated Outcome and assessment information set (OASIS) form - version C - Resumption of Care


name: Outcome and assessment information set (OASIS) form - version C - Resumption of Care


name: Deprecated Outcome and assessment information set (OASIS) form - version C - Follow-Up


name: Outcome and assessment information set (OASIS) form - version C - Follow-Up


name: Deprecated Outcome and assessment information set (OASIS) form - version C - Transfer to facility


name: Outcome and assessment information set (OASIS) form - version C - Transfer to facility


name: Deprecated Outcome and assessment information set (OASIS) form - version C - Discharge from agency


name: Outcome and assessment information set (OASIS) form - version C - Discharge from agency


name: Patient &or caregiver drug education intervention:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Patient &or caregiver drug education intervention


name: Prior medication management:-:Pt:^Patient:-:CMS Assessment


name: Plan of care synopsis:-:RptPeriod:^Patient:-:CMS Assessment


name: Current payment sources for home care:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Reason for assessment:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Date of Physician-ordered Start of Care (Resumption of Care):Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Inpatient discharge facility within the past 14D:Type:14D:^Patient:Nom:CMS Assessment


name: Inpatient stay within last 14D - ICD code:Prid:14D:^Patient:Nom:OASIS-C


name: Frequency of pain interfering with activity or movement:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Pressure injury assessment was conducted:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Oldest non-epithelialized stage 2 pressure injury present at discharge:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Diameter.long:Len:Pt:Pressure injury.largest stage 3 or 4:Qn:OASIS-C


name: Depth:Len:RptPeriod:Pressure injury.largest stage 3 or 4:Qn:CMS Assessment


name: Status of most problematic pressure injury:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Stage of most problematic pressure injury:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Stasis pressure injury:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Number of stasis ulcers:Num:RptPeriod:^Patient:Ord:CMS Assessment


name: Status of most problematic stasis pressure injury:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Status of most problematic surgical wound:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Exertion level causing shortness of breath:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Respiratory treatments administered at home:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Symptoms in heart failure patients:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Heart failure follow-up:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: When urinary incontinence occurs:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Standardized depression screening was conducted:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Bathing - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Toilet transferring - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Toileting hygiene - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Transferring - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Locomotion - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Feeding - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Prepare light meals - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Standardized fall risk assessment was conducted:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Drug regimen review identified potential medication issues:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Medication intervention since admission &or reentry:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Patient &or caregiver received high risk drug education:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Patient &or caregiver received high risk drug education


name: Oral medication management - prior ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Injectable medication management - prior ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with ADL:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with IADL:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with medication administration:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with medical procedures &or treatments:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with management of equipment:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with supervision and safety:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Non-agency caregiver ability and willingness to assist with advocacy or facilitation of patient participation:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Advocacy or facilitation of patient participation


name: ADL or IADL assistance frequency from any caregiver:Find:Pt:^Patient:Ord:CMS Assessment


name: Plan of care includes patient-specific parameters for notifying physician of changes:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Plan of care includes diabetic foot care:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Plan of care includes fall prevention interventions:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Plan of care includes depression intervention:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Plan of care includes intervention to monitor and mitigate pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Intervention to monitor and mitigate pain


name: Plan of care includes intervention to prevent pressure injuries:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Plan of care includes pressure injury treatment - moist healing:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Emergent care utilized:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Reason for emergent care:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Deprecated Discharge disposition [CMS Assessment]


name: Reason for hospitalization:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Risk of developing pressure injuries:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Patient &or caregiver drug education intervention:Find:Pt:^Patient:Ord:OASIS-C


name: Management of injectable medications - ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Management of oral medications - ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Types and sources of assistance:-:RptPeriod:^Patient:-:CMS Assessment


name: Herpes simplex virus 2 Ab.IgG^2nd specimen:ACnc:Pt:Ser:Qn:IA


name: Varicella zoster virus Ab.IgM^1st specimen:ACnc:Pt:Ser:Qn:IA


name: Beta hydroxybutyrate^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^1M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^5M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Lactate^1M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^3M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^5M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Albumin:MCnc:12H:Urine:Qn:Detection limit <= 20 mg/L


name: Cells.CD3+TCR alpha beta+/100 cells:NFr:Pt:Body fld:Qn


name: Cells.CD3+TCR gamma delta+/100 cells:NFr:Pt:Body fld:Qn


name: Liver kidney microsomal 1 Ab:Titr:Pt:Ser:SemiQn:IF


name: Muscle specific receptor tyrosine kinase Ab:ACnc:Pt:Ser:Qn:IA


name: Cells.terminal deoxyribonucleotidyl transferase:PrThr:Pt:Body fld:Ord


name: Toxoplasma gondii DNA:PrThr:Pt:Body fld:Ord:Probe.amp.tar


name: Spermatozoa.progressive.grade 3/100 spermatozoa^post concentration:NFr:Pt:Semen:Qn


name: Spermatozoa.progressive.grade 2/100 spermatozoa^post concentration:NFr:Pt:Semen:Qn


name: Spermatozoa.progressive.grade 1/100 spermatozoa^post concentration:NFr:Pt:Semen:Qn


name: Deprecated Nuclear Ab [Titer] in Synovial fluid by Immunofluorescence


name: Nuclear Ab pattern:Imp:Pt:Synv fld:Nom:IF


name: Tubular basement membrane Ab:ACnc:Pt:Ser:Qn


name: Deprecated Soluble liver Ab [Presence] in Serum by Immunoassay


name: Chromosome 18 aneuploidy:Find:Pt:Amnio fld/CVS:Nom:FISH


name: Chromosome 13 aneuploidy:Find:Pt:Amnio fld/CVS:Nom:FISH


name: Deprecated Outcome and assessment information set (OASIS) form - version C - Death at home


name: Outcome and assessment information set (OASIS) form - version C - Death at home


name: Lymphocytes.activated T cells/100 lymphocytes.small:NFr:Pt:BAL:Qn


name: Lymphocytes.activated T cells/100 lymphocytes.small:NFr:Pt:Bronchial:Qn


name: Calcitriol^2H post dose calcium:SCnc:Pt:Ser/Plas:Qn


name: Calcitriol^2H post dose calcium:MCnc:Pt:Ser/Plas:Qn


name: Calcitriol^3H post dose calcium:SCnc:Pt:Ser/Plas:Qn


name: Calcitriol^3H post dose calcium:MCnc:Pt:Ser/Plas:Qn


name: Calcitriol^1H post dose calcium:SCnc:Pt:Ser/Plas:Qn


name: Calcitriol^1H post dose calcium:MCnc:Pt:Ser/Plas:Qn


name: 11-Ketoandrosterone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Ketoandrosterone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Ketoandrosterone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Ketoandrosterone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Ketoandrosterone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Ketoandrosterone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Ketoetiocholanolone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Ketoetiocholanolone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Ketoetiocholanolone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Deoxycorticosterone^30M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycorticosterone^1H post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1D post dose dexamethasone:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^2D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^2D post dose dexamethasone:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1D post dose metyraPONE:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1D post dose metyraPONE:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^2D post dose metyraPONE:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^2D post dose metyraPONE:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^pre 250 ug corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^45M post 250 ug corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 11-Hydroxyandrosterone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Hydroxyandrosterone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Hydroxyandrosterone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Hydroxyandrosterone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Hydroxyandrosterone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Hydroxyandrosterone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Hydroxyetiocholanolone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Hydroxyetiocholanolone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Hydroxyetiocholanolone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Hydroxyetiocholanolone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 11-Hydroxyetiocholanolone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 11-Hydroxyetiocholanolone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 17-Ketogenic steroids^pre dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Ketogenic steroids^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Hydroxypregnenolone^1D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^2D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^10th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^11th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^12th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^1st specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^2nd specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^3rd specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^4th specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^5th specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^6th specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^7th specimen post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn


name: 18-Hydroxycortisol^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 18-Hydroxycortisol^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycorticosterone^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycorticosterone^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycortisol^1D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycortisol^2D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: Calcidiol^2H post dose calcium:SCnc:Pt:Ser/Plas:Qn


name: Calcidiol^3H post dose calcium:SCnc:Pt:Ser/Plas:Qn


name: Calcidiol^1H post dose calcium:SCnc:Pt:Ser/Plas:Qn


name: 3-Alpha-Androstanediol glucuronide^pre dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 3-Alpha-Androstanediol glucuronide^1D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: Alpha cortolone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortolone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortolone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortolone^pre dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortolone^pre dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortolone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortolone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: Androsterone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: Androsterone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: Other error requiring modification:Type:Pt:^Patient:Ord:MDSv3


name: Other error requiring modification.other specified:Type:Pt:^Patient:Nom:MDSv3


name: Reasons for inactivation - event did not occur:Find:Pt:^Patient:Ord:MDSv3


name: Other error requiring error requiring inactivation:Find:Pt:^Patient:Ord:MDSv3


name: Other error requiring error requiring inactivation.other specified:Find:Pt:^Patient:Nom:MDSv3


name: Medicare non-therapy Part A HIPPS code:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Medicare non-therapy Part A - RUG version code:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Medicare non-therapy Part A - RUG version code


name: Alternate state Medicaid billing - RUG group:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Alternate state Medicaid billing - RUG version code:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Alternate state Medicaid billing - RUG version code


name: One or more unhealed pressure injuries stage 1 or higher:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Speech-language pathology and audiology services - individual minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Occupational therapy - individual minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Physical therapy - individual minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Participation in assessment:Find:RptPeriod:^Guardian or legally authorized representative:Nom:CMS Assessment


name: Items from most recent prior OBRA or scheduled PPS assessment:-:Pt:^Patient:-


name: Items from most recent prior OBRA or scheduled PPS assessment


name: Visual function - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Visual function - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Infection of the foot:Find:Pt:^Patient:Ord:MDSv3


name: 3-Alpha-Androstanediol glucuronide^2D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn


name: 3-Alpha-Androstanediol glucuronide^pre dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 3-Alpha-Androstanediol glucuronide^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 3-Alpha-Androstanediol glucuronide^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Androstanolone^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Androstanolone^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^post 25 mg captopril PO:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^pre 25 mg captopril PO:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^2H post 25 mg captopril PO:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^3H post 25 mg captopril PO:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^3H post 25 mg captopril PO:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^1H post 25 mg captopril PO:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^2H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^15M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^3H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^30M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^1H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^pre 250 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Deoxycortisol^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^pre dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^pre dose dexamethasone:MRat:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^pre dose dexamethasone:MCnc:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^pre dose dexamethasone:MRat:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: 5-Alpha tetrahydrocortisol^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortol^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortol^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortol^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortol^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortol^pre dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortol^pre dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortol^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: Alpha cortol^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: Alpha cortolone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: Newborn screening test results panel:-:Pt:Bld.dot:-


name: Progesterone^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Number of occult blood specimens recommended by testing kit protocol:Num:Pt:Stool:Qn


name: HEDIS 2010 Tests used in early prenatal care - ABO & Rh (PPC-C):-:Pt:^Patient:-


name: HEDIS 2010 Tests used in early prenatal care - ABO & Rh (PPC-C)


name: HEDIS 2010-2013 Tests used in early prenatal care - Rubella (PPC-C):-:Pt:^Patient:-


name: Androsterone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: Androsterone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: Androsterone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: Androsterone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: C peptide^190M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^3.3H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: C peptide^1.3H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Humidifier heated wire temperature differential setting:Temp:Pt:Ventilator airway circuit:Qn


name: Tidal volume.spontaneous min setting:Vol:Pt:Ventilator.alarm:Qn


name: Tidal volume.inspired max setting:Vol:Pt:Ventilator.alarm:Qn


name: Tidal volume.exhaled max setting:Vol:Pt:Ventilator.alarm:Qn


name: Tubular basement membrane Ab:Titr:Pt:Ser:SemiQn:IF


name: U1 small nuclear ribonucleoprotein Ab:ACnc:Pt:Ser:Qn:IA


name: Protein fractions.oligoclonal bands.IgG:PrThr:Pt:Ser/Plas:Ord:Isoelectric focusing


name: Protein fractions.oligoclonal bands.IgM:PrThr:Pt:Ser/Plas:Ord:Isoelectric focusing


name: Coxiella burnetii Ab.IgM^2nd specimen:PrThr:Pt:Ser:Ord:IF


name: Legionella pneumophila Ab.IgG^1st specimen:PrThr:Pt:Ser:Ord:IF


name: Legionella pneumophila Ab.IgG^2nd specimen:PrThr:Pt:Ser:Ord:IF


name: Mycoplasma pneumoniae Ab.IgG^1st specimen:PrThr:Pt:Ser:Ord:IA


name: Mycoplasma pneumoniae Ab.IgG^2nd specimen:PrThr:Pt:Ser:Ord:IA


name: Chlamydia sp Ab.IgG^1st specimen:PrThr:Pt:Ser:Ord:IA


name: Chlamydia sp Ab.IgG^2nd specimen:PrThr:Pt:Ser:Ord:IA


name: Coxiella burnetii Ab.IgG^1st specimen:PrThr:Pt:Ser:Ord:IF


name: Coxiella burnetii Ab.IgG^2nd specimen:PrThr:Pt:Ser:Ord:IF


name: Lipid panel with direct LDL:-:Pt:Ser/Plas:Qn


name: Biotinidase deficiency newborn screening comment-discussion:Txt:Pt:Bld.dot:Nar


name: Biotinidase deficiency newborn screening comment-discussion


name: Infant factors that affect newborn screening interpretation:Find:Pt:^Patient:Nom


name: Obstetric estimation of gestational age:Time:Pt:^Patient:Qn


name: State printed on filter paper card:ID:Pt:NBS card:Nom


name: Newborn screen card data panel:-:Pt:Bld.dot:-


name: Conditions tested for in this newborn screening study:ID:Pt:Bld.dot:Nom


name: Conditions tested for in this newborn screening study


name: Newborn conditions with equivocal markers:Prid:Pt:Bld.dot:Nom


name: Unique bar code number:ID:Pt:Current sample:Nom


name: Newborn screening short narrative summary:Txt:Pt:^Patient:Nar


name: Newborn screening short narrative summary


name: Corticotropin^20M post XXX challenge:MCnc:Pt:Plas:Qn


name: Lactate^40M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate^6M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Basement membrane zone BP180 Ab:ACnc:Pt:Ser:Qn:IA


name: IKBKG gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: TNFRSF13B gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: WAS gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Procollagen type III.N-terminal propeptide:ACnc:Pt:Ser:Qn


name: IKBKG gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: TNFRSF13B gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: WAS gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Coagulation factor XIII inhibitor:PrThr:Pt:PPP:Ord:Coag


name: Platelet factor 4 heparin complex induced Ab:PrThr:Pt:Ser/Plas:Ord:IA


name: Coagulation surface induced.factor substitution^immediately after addition of normal plasma/Coagulation surface induced:TRto:Pt:PPP:Qn:Coag


name: Histoplasma capsulatum Ag:MCnc:Pt:Body fld:Qn


name: Trimipramine & Nortrimipramine panel:-:Pt:Ser/Plas:Qn


name: Campylobacter jejuni+Campylobacter coli Ag:PrThr:Pt:Stool:Ord


name: Salmonella typhi O Vi Ab:PrThr:Pt:Ser:Ord


name: Myeloperoxidase Ab & Proteinase 3 panel:-:Pt:Ser:Qn


name: Immunoglobulin light chains.free panel:-:Pt:Ser:Qn


name: Thyroglobulin & Thyroglobulin Ab panel:-:Pt:Ser/Plas:Qn


name: Thyroglobulin & Thyroglobulin Antibody panel


name: Complete blood count W Ordered Manual Differential panel:-:Pt:Bld:Qn


name: Complete blood count W Ordered Manual Differential panel


name: Dehydroepiandrosterone^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: Dehydroepiandrosterone^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: Dehydroepiandrosterone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: Dehydroepiandrosterone^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: Dehydroepiandrosterone^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: Dehydroepiandrosterone^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: Organic acidemia conditions suspected:Prid:Pt:Bld.dot:Nom


name: Fatty acid oxidation conditions suspected:Prid:Pt:Bld.dot:Nom


name: Amino acidemia disorder suspected:Prid:Pt:Bld.dot:Nom


name: HEDIS 2010 Tests used in early prenatal care (PPC-C):-:Pt:^Patient:-


name: HEDIS 2010 Tests used in early prenatal care (PPC-C)


name: HEDIS 2010-2013 Codes to identify anticonvulsant serum concentration monitoring tests - carBAMazepine (MPM-E):-:Pt:^Patient:-


name: HEDIS 2010, 2011 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E):-:Pt:^Patient:-


name: HEDIS 2010, 2011 Codes to identify physiologic monitoring tests - Blood urea nitrogen (BUN) (MPM-A):-:Pt:^Patient:-


name: HEDIS 2010,2011 Codes to identify physiologic monitoring tests - Serum creatinine (SCr) (MPM-A):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify physiologic monitoring tests (MPM-A):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify physiologic monitoring tests (MPM-A)


name: HEDIS 2010 Codes to identify evidence of nephropathy (CDC-K):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify evidence of nephropathy (CDC-K)


name: HEDIS 2010 Codes to identify nephropathy screening tests (CDC-J):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify nephropathy screening tests (CDC-J)


name: HEDIS 2010 Codes to identify LDLc screening (CDC-H):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify LDLc screening (CDC-H)


name: HEDIS 2010 Codes to identify LDLc screening (CMC-D):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify LDLc screening (CMC-D)


name: HEDIS 2010-2013 Codes to identify Chlamydia screening (CHL-C):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify sexually active women (CHL-B):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify sexually active women (CHL-B)


name: HEDIS 2010 Codes to identify colorectal cancer screening (COL-A):-:Pt:^Patient:-


name: HEDIS 2010 Codes to identify colorectal cancer screening (COL-A)


name: Prescription for medical equipment or product:Find:Pt:{Setting}:Doc:{Role}


name: Prescription for medical equipment or product


name: Prescription for diagnostic or specialist care:Find:Pt:{Setting}:Doc:{Role}


name: Prescription for diagnostic or specialist care


name: Coagulation dilute Russell viper venom induced.excess phospholipid:Time:Pt:PPP:Qn


name: Activated clotting time.kaolin induced:Time:Pt:PPP^Control:Qn:Coag


name: Snowshoe hare virus Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: Thyrotropin^5M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Cucumis melo cantalupensis basophil bound Ab:ACnc:Pt:Bld:Qn:LHR


name: Cucumis melo cantalupensis Ab.IgG4:MCnc:Pt:Ser:Qn


name: Cucumis melo cantalupensis Ab.IgG.RAST class


name: Cucumis melo spp Ab.IgG.RAST class:PrThr:Pt:Ser:Ord


name: Cucumis melo cantalupensis Ab.IgG:ACnc:Pt:Ser:Qn


name: Cucumis melo cantalupensis Ab.IgE.RAST class


name: Cucumis melo cantalupensis Ab.IgE:ACnc:Pt:Ser:Qn


name: Cucumis melo spp basophil bound Ab:ACnc:Pt:Bld:Qn:LHR


name: Pregnanediol^pre high dose dexamethasone:MCnc:24H:Urine:Qn


name: Pregnanediol^pre high dose dexamethasone:MRat:24H:Urine:Qn


name: Pregnanediol^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: Pregnanediol^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: Pregnanediol^2D post dose dexamethasone:MCnc:24H:Urine:Qn


name: Pregnanediol^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: C peptide^100M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Influenza virus A H1.neuraminidase inhibitor resistance:Susc:Pt:XXX:Ord:Genotyping


name: Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance:Susc:Pt:XXX:Ord:Genotyping


name: Influenza virus A+B.neuraminidase inhibitor resistance:Susc:Pt:XXX:Ord:Genotyping


name: Clostridioides difficile glutamate dehydrogenase:PrThr:Pt:Stool:Ord


name: C. difficile Glutamate Dehydrogenase Measurement


name: B little g super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: B little g super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: B little g super little a Ag:PrThr:Pt:RBC:Ord


name: AIRE gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: ADNFLE gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Basement membrane zone BP230 Ab:ACnc:Pt:Ser/Plas:Qn


name: Borrelia burgdorferi C6 Ab:PrThr:Pt:Ser:Ord


name: CACNA1S+SCN4A gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CDKN2A+CDK4 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CFTR+PRSS1+SPINK1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Coccidioides immitis Ab.IgG:PrThr:Pt:CSF:Ord:Comp fix


name: CPVT1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: DPYD2A gene targeted mutation analysis:Arb:Pt:Bld/Tiss:Ord:Molgen


name: FECH gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: FLCN gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Glucose^3H post 75 g glucose PO:MCnc:Pt:Urine:Qn


name: Glucose^4th specimen post dose lactose:MCnc:Pt:Ser/Plas:Qn


name: Glucose^5th specimen post dose lactose:MCnc:Pt:Ser/Plas:Qn


name: IDUA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Influenza virus A H2 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Insulin-like growth factor^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: KRIT1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Legionella pneumophila 1+3+4+5+6+8 Ab:PrThr:Pt:Ser:Ord


name: MSH2 gene+MLH1 gene+MSH6 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: PKD2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: HLA-B SBT:Type:Pt:Bone mar:Nom:High resolution


name: RYR1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: SCN4A gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Inpatient procedure relevant to plan of care:Type:Pt:^Patient:Nom:OASIS-C


name: Date pressure injury first identified:Date:RptPeriod:Pressure injury.oldest non-epithelialized stage 2:Qn:CMS Assessment


name: C little h super little a Ag:PrThr:Pt:RBC:Ord


name: C little h super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: C little o super little a Ag:PrThr:Pt:RBC:Ord


name: C little o super little b Ag:PrThr:Pt:RBC:Ord


name: C little s super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: C little s super little a Ag:PrThr:Pt:Ser/Plas:Ord


name: D little o super little b Ab:PrThr:Pt:Ser/Plas:Ord


name: D little o super little b Ag:PrThr:Pt:RBC:Ord


name: G little o super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: I little n super little b Ag:PrThr:Pt:RBC:Ord


name: I little n super little b Ab:PrThr:Pt:Ser/Plas:Ord


name: J little r super little a Ag:PrThr:Pt:RBC:Ord


name: J little r super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: K little n super little a Ag:PrThr:Pt:RBC:Ord


name: K little n super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: K little n super little b Ab:PrThr:Pt:Ser/Plas:Ord


name: K little n super little b Ag:PrThr:Pt:RBC:Ord


name: M little c C super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: R little g super little a Ag:PrThr:Pt:RBC:Ord


name: R little g super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: W little r super little a Ag:PrThr:Pt:RBC:Ord


name: W little r super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: Y little k super little a Ag:PrThr:Pt:RBC:Ord


name: Y little k super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: Urinalysis complete W Reflex Culture panel:-:Pt:Urine:-


name: Urinalysis complete W Reflex Culture panel


name: Current number of unhealed (non-epithelialized) pressure injuries at each stage:-:Pt:^Patient:-:OASIS-C


name: When confused within the last 14D:Find:14D:^Patient:Ord:CMS Assessment


name: Current payment sources for home care.other specified:Find:Pt:^Patient:Nom:OASIS-C


name: Inpatient discharge facility.other specified:Type:Pt:^Patient:Nom:OASIS-C


name: Swing bed clinical change assessment:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Entry &or discharge reporting:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Multidrug-resistant organism (MDRO) in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Wound infection (other than foot) in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Neurogenic bladder in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Obstructive uropathy in the last 7D:Find:7D:^Patient:Ord:MDSv3


name: Huntington's disease in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Tourette's syndrome in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Psychotic disorder (other than schizophrenia) in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Respiratory failure in last 7D:Find:7D:^Patient:Ord:MDSv3


name: Staff pain assessment interview should be conducted:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Frequency of indicator of pain or possible pain:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: Frequency of indicator of pain or possible pain


name: Unable to examine oral or dental status:Find:Pt:^Patient:Ord:MDSv3


name: Patient health questionnaire 2 item:-:2W:^Patient:-:PHQ.CMS


name: Prior Functioning ADL and IADL:-:RptPeriod:^Patient:-:CMS Assessment


name: Resident has one or more unhealed pressure injuries at stage 1 or higher:Find:Pt:^Patient:Ord:MDSv3


name: Date of oldest stage 2 pressure injury:Date:RptPeriod:Pressure injury.oldest non-epithelialized stage 2:Qn:CMS Assessment


name: Other open lesion(s) on the foot:Find:Pt:^Patient:Ord:MDSv3


name: Number of D injection of any type were received in last 5D or since admission &or reentry if less than 7D:Num:7D:^Patient:Qn:MDSv3


name: Number of D insulin injections were received in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D insulin injections were received in last 7D or since admission &or reentry if less than 7D


name: Number of D the physician changed the resident's insulin orders in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Antibiotic received in last 7D or since admission &or reentry if less than 7D:Find:7D:^Patient:Ord:MDSv3


name: Diuretic received in last 7D or since admission &or reentry if less than 7D:Find:7D:^Patient:Ord:MDSv3


name: Date of influenza vaccination:Date:Pt:^Patient:Qn


name: Speech-language pathology and audiology services:-:Pt:^Patient:-:MDSv3


name: Speech-language pathology and audiology services


name: Speech-language pathology and audiology services - concurrent minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Speech-language pathology and audiology services - group minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Occupational therapy - concurrent minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Occupational therapy - group minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Physical therapy - concurrent minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Physical therapy - group minutes in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Resident's overall goal established during assessment process:Find:Pt:^Patient:Nom:MDSv3


name: Information source for overall goal:Find:Pt:^Patient:Nom:MDSv3


name: Active discharge planning in place for resident return to community:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Determination made by resident and core planning team regarding discharge to community:Find:Pt:^Patient:Nom:MDSv3


name: Resident has been asked about returning to the community:Find:Pt:^Patient:Nom:MDSv3


name: Wants to talk to someone about the possibility of returning to the community:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Referral has been made to the local contact agency:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Prior assessment brief interview for mental status summary score:Score:Pt:^Patient:Qn:MDSv3


name: Prior assessment resident mood interview (PHQ-9) total severity score:Score:Pt:^Patient:Qn:MDSv3


name: Prior assessment staff assessment of resident mood interview (PHQ-9) total severity score:Score:Pt:^Patient:Qn:MDSv3


name: Care Area Assessment (CAA) Summary:-:Pt:^Patient:-:MDSv3


name: Care Area Assessment (CAA) and care planning:-:Pt:^Patient:-:MDSv3


name: Care Area Assessment (CAA) and care planning


name: Care Area Assessment (CAA) results:-:Pt:^Patient:-:MDSv3


name: Delirium - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Delirium - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Cognitive loss &or dementia - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Cognitive loss &or dementia - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Communication - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Communication - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: ADL functional &or rehabilitation potential - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: ADL functional &or rehabilitation potential - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Urinary incontinence and indwelling catheter - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Urinary incontinence and indwelling catheter - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Psychosocial well being - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Psychosocial well being - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Mood state - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Mood state - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Behavioral symptoms - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Behavioral symptoms - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Activities - care area triggered:Find:Pt:^Patient:Ord:MDSv3


name: Activities - addressed in care plan:Find:Pt:^Patient:Ord:MDSv3


name: Falls - care area triggered:Find:Pt:^Patient:Ord:MDSv3